Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Liu (Chengdu (Sichuan), China), Z. Yuan (Chengdu (Sichuan), China), W. Tao (Chengdu (Sichuan), China), F. Wen (Chengdu (Sichuan), China). Overexpression of ISCU can extenuate mitochondrial damage, reduce EMT and bleomycin-induced pulmonary fibrosis. 557

Member's Comments

No comment yet.

Related content which might interest you: HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Cigarette-decreased NAD/SIRT1 aggravates pulmonary fibrosis by promoting senescence of alveolar type 2 cells through autophagy inhibition and mitochondrial oxidative stress induction Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2004; 24: 57-65 Year: 2004 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 180-189 Year: 2001 NADPH oxidase 4 deficiency protects from bleomycin-induced epithelial cell death and pulmonary fibrosis Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed SOD2 expression and reduces proliferation in human primary pulmonary fibroblasts Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002 Extracellular HSP90a promotes pulmonary fibrosis by impairing autophagic flux in lung fibroblasts Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Heterozygous SOD2 deletion deteriorated chronic intermittent hypoxia-induced lung inflammation and vascular remodeling through mtROS-NLRP3 signaling pathway Source: Virtual Congress 2020 – New insights into sleep apnoea: from diagnosis to treatment Year: 2020 Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Nintedanib inhibits contractile activity of lung myofibroblasts in a cellular model of scleroderma associated pulmonary fibrosis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015